Effectiveness of a dedicated day hospital for management of acute sickle cell pain

Haematologica

Volumn 92, Issue 6, 2007, Pages 854-

  Adewoye, Adeboye H ^a   Nolan, Vikki ^a   McMahon, Lillian ^a   Ma, Qianli ^a   Steinberg, Martin H ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OPIATE; NARCOTIC ANALGESIC AGENT;

ANALGESIA; ARTICLE; CONTROLLED STUDY; COST OF ILLNESS; DAY HOSPITAL; DRUG DOSE TITRATION; EMERGENCY WARD; FEMALE; HEALTH CARE ACCESS; HEALTH CARE FACILITY; HOSPITAL ADMISSION; HOSPITAL CARE; HOSPITAL COST; HUMAN; HYDRATION; INTERNATIONAL CLASSIFICATION OF DISEASES; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PAIN; PATIENT MONITORING; SICKLE CELL ANEMIA; DISEASE MANAGEMENT; EMERGENCY HEALTH SERVICE; LETTER; PAIN CLINIC;

ANALGESICS, OPIOID; ANEMIA, SICKLE CELL; DISEASE MANAGEMENT; EMERGENCY MEDICAL SERVICES; HUMANS; PAIN; PAIN CLINICS;

EID: 34347240967     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.10757     Document Type: Article

References (10)

1. Shapiro BS, Dinges DF, Orne EC, Bauer N, Reilly LB, Whitehouse WG, et al. Home management of sickle cell-related pain in children and adolescents: natural history and impact on school attendance. Pain 1995;61:139-44.
2. Steinberg MH. Predicting clinical severity in sickle cell anaemia. Br J Haematol 2005;129:465-81.
3. Buchanan GR, Debaun MR, Quinn CT, Steinberg MH. Sickle cell disease. Hematology (Am Soc Hematol Educ Program) 2004:35-47.
4. Bonds DR. Three decades of innovation in the management of sickle cell disease: the road to understanding the sickle cell disease clinical phenotype. Blood Reviews. 2005;19:99-110.
5. Steinberg MH, Barton F, Castro O, Pegelow CH, Ballas SK, Kutlar A, et al. Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment. JAMA 2003;289:1645-51.
6. Moore RD, Charache S, Terrin ML, Barton FB, Ballas SK. Cost-effectiveness of hydroxyurea in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. Am J Hematol 2000;64:26-31.
7. Wright J, Bareford D, Wright C, Augustine G, Olley K, Musamadi L, et al. Day case management of sickle pain: 3 years experience in a UK sickle cell unit. Br J Haematol 2004;126:878-80.
8. Benjamin LJ, Swinson GI, Nagel RL. Sickle cell anemia day hospital: an approach for the management of uncomplicated painful crises. Blood 2000;95:1130-6.
9. Platt OS, Thorington BD, Brambilla DJ, Milner PF, Rosse WF, Vichinsky E, et al. Pain in sickle cell disease. Rates and risk factors. N Engl J Med 1991;325:11-6.
10. Federal R. Centers for Medicare and Medicaid Services (CMS), HHS. Federal Register 2006;71:47869-48351.